Skip to main content
. 2019 Mar 18;17(5):4039–4045. doi: 10.3892/etm.2019.7409

Figure 2.

Figure 2.

Comparison between GASL1 serum levels in patients with gastric cancer and healthy controls. (A) Relative GASL1 expression levels in serum samples from patients with gastric cancer and healthy controls were determined by reverse transcription-quantitative polymerase chain reaction. (B) Receiver operating characteristic curve analysis of GASL1 expression in serum samples. *P<0.05 vs. Control. GASL1, growth arrest associated lncRNA 1.